Exane Derivatives’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$554	Hold	78	–	–	﹤0.01%	559
2022 Q1	$563	Hold	78	–	–	﹤0.01%	845
2021 Q4	$697	Sell	78 -4,688	-98%	-$41.9K	﹤0.01%	726
2021 Q3	$167K	Buy	4,766 +576	+14%	+$20.2K	0.04%	420
2021 Q2	$93.2K	Buy	+4,190	New	+$93.2K	0.02%	536